Medicine, Faith and Fitness Converge in Lung Cancer Recovery
January 8, 2015 · No comments
During years of mountain biking, Jon Wilmot has toiled up the Waterton Canyon Trail when...
Reprogramming Stem Cells May Prevent Cancer After Radiation
December 29, 2014 · No comments
"The body didn't evolve to deal with leaking nuclear reactors and CT scans. It evolved to deal with only a few cells at a time receiving dangerous doses of radiation or other insults to their DNA," says James DeGregori, PhD.
Mutations Need Help From Aging Tissue to Cause Leukemia
December 18, 2014 · Comments Off
"We had been looking inside cells for the causes of cancer, but that wasn't enough. There was something happening outside the cells that mattered," says James DeGregori, PhD.
A Conversation with Marileila Garcia, PhD
December 15, 2014 · Comments Off
The goal of personalized medicine is to match the genetics of an individual’s cancer with...
3 San Antonio Studies Target Androgen in Breast Cancer
December 11, 2014 · Comments Off
Three studies presented by University of Colorado Cancer Center researchers at the San Antonio Breast Cancer Symposium 2014 demonstrate the effects of blocking androgen receptors in breast cancer.
Tricking prostate cancer
December 5, 2014 · Comments Off
With a background in biochemistry, fat metabolism and genetics, University of Colorado Cancer Center investigator...
One-Two Punch of Drugs Better Than Either Alone Against Colorectal Cancer
November 25, 2014 · Comments Off
CU lab study and clinical trial target two of the most commonly mutated gene signaling pathways in cancer, at the same time.
Next-Gen Melanoma Drug, TAK-733, Excels in Lab Tests
November 11, 2014 · Comments Off
A University of Colorado Cancer Center study published online this week in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733, a small molecule inhibitor of MEK1/2.
Radiation of the brain may lead to cognitive dysfunction in cancer patients
November 7, 2014 · Comments Off
Radiation and chemotherapy are the two most common treatments given to people diagnosed with cancer....
Bitter melon juice prevents pancreatic cancer in mouse models
November 7, 2014
NTRK1: a new oncogene and target in lung cancer
November 7, 2014
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer clinical trials cancer grants cancer prevention cancer research colorado Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Have you liked us on FB yet? If not, be sure to do so for the latest updates on research, clinical trials, and events on.fb.me/1BRkDDh